EA
OSIR

Emerald Acquisition’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Emerald Acquisition’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$317K Sell
63,806
-678
-1% -$3.47K ﹤0.01% 2590
2016
Q2 		$328K Buy
+64,484
New +$347K ﹤0.01% 2614

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Emerald Acquisition's OSIR Position: Q3 2016 in Review

Emerald Acquisition reduced its Osiris Therapeutics, Inc. Common Stock (OSIR) stake by 1.1% in Q3 2016, selling an estimated $3.47K and leaving 63,806 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

Emerald Acquisition first reported a position in OSIR in Q2 2016 and has held it in 2 quarters since. The position peaked at $328K in Q2 2016. 63 funds tracked by Wall St. Rank hold OSIR as of Q3 2016.

  • Emerald Acquisition held 63,806 shares of Osiris Therapeutics, Inc. Common Stock worth $317K as of Q3 2016.
  • Emerald Acquisition sold 678 Osiris Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $3.47K.
  • Osiris Therapeutics, Inc. Common Stock made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2590 holding.
  • Emerald Acquisition first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Osiris Therapeutics, Inc. Common Stock position peaked at $328K in Q2 2016.
  • 63 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.